Literature DB >> 28193802

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves: A Meta-Analysis.

Konstantinos C Siontis1, Xiaoxi Yao1, Bernard J Gersh1, Peter A Noseworthy2.   

Abstract

Entities:  

Keywords:  anticoagulant; atrial fibrillation; meta-analysis; valve

Mesh：

Substances：

Year:  2017        PMID： 28193802     DOI： 10.1161/CIRCULATIONAHA.116.026793

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

1.  Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.

Authors:  Konstantinos C Siontis; Xiaosong Zhang; Ashley Eckard; Nicole Bhave; Douglas E Schaubel; Kevin He; Anca Tilea; Austin G Stack; Rajesh Balkrishnan; Xiaoxi Yao; Peter A Noseworthy; Nilay D Shah; Rajiv Saran; Brahmajee K Nallamothu
Journal:  Circulation       Date:  2018-10-09       Impact factor: 29.690

2.  Atrial Arrhythmias in Pulmonary Hypertension: Pathogenesis, Prognosis and Management.

Authors:  Brett Wanamaker; Thomas Cascino; Vallerie McLaughlin; Hakan Oral; Rakesh Latchamsetty; Konstantinos C Siontis
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-03

Review 3.  Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation.

Authors:  Arnaud Bisson; Denis Angoulvant; Raphael Philippart; Nicolas Clementy; Dominique Babuty; Laurent Fauchier
Journal:  Adv Ther       Date:  2017-05-10       Impact factor: 3.845

4.  Bioprosthetic Valve Thrombosis while on a Novel Oral Anticoagulant for Atrial Fibrillation.

Authors:  Marissa O'Callaghan; Rebecca Chester; Caleb Scheckel; Justin Z Lee; Regis Fernandes; Fadi Shamoun
Journal:  CASE (Phila)       Date:  2018-03-07

5.  Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial.

Authors:  Patricia O Guimarães; Sean D Pokorney; Renato D Lopes; Daniel M Wojdyla; Bernard J Gersh; Anna Giczewska; Anthony Carnicelli; Basil S Lewis; Michael Hanna; Lars Wallentin; Dragos Vinereanu; John H Alexander; Christopher B Granger
Journal:  Clin Cardiol       Date:  2019-04-09       Impact factor: 2.882

6.  Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation.

Authors:  Athanasios Samaras; Eleni Vrana; Anastasios Kartas; Dimitrios V Moysidis; Andreas S Papazoglou; Ioannis Doundoulakis; George Fotos; Georgios Rampidis; Dimitrios G Tsalikakis; Georgios Efthimiadis; Haralambos Karvounis; Apostolos Tzikas; George Giannakoulas
Journal:  BMC Cardiovasc Disord       Date:  2021-09-18       Impact factor: 2.298

7.  Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009.

Authors:  Carla Benea; Kimberly A Turner; Michelle Roseman; Lisa A Bero; Joel Lexchin; Erick H Turner; Brett D Thombs
Journal:  Syst Rev       Date:  2020-04-08

Review 8.  Heart-Brain Relationship in Stroke.

Authors:  Roger E Kelley; Brian P Kelley
Journal:  Biomedicines       Date:  2021-12-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.